Americana Partners, LLC Bristol Myers Squibb CO Transaction History

Americana Partners, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$47.98 - $54.4 $23,270 - $26,384	485 Added 10.15%	5,263 $285,000
Q4 2023 Jan 25, 2024	SELL	$48.48 - $57.85 $125,660 - $149,947	-2,592 Reduced 35.17%	4,778 $245,000
Q3 2023 Nov 07, 2023	SELL	$57.89 - $64.73 $1.06 Million - $1.19 Million	-18,314 Reduced 71.31%	7,370 $427,000
Q2 2023 Jul 31, 2023	SELL	$63.71 - $70.74 $38,990 - $43,292	-612 Reduced 2.33%	25,684 $1.64 Million
Q1 2023 May 08, 2023	SELL	$65.71 - $74.53 $5,585 - $6,335	-85 Reduced 0.32%	26,296 $1.82 Million
Q4 2022 Jan 30, 2023	SELL	$68.48 - $81.09 $1.02 Million - $1.2 Million	-14,839 Reduced 36.0%	26,381 $1.9 Million
Q3 2022 Nov 10, 2022	BUY	$0.13 - $76.84 $2,249 - $1.33 Million	17,307 Added 72.37%	41,220 $2.92 Million
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $833,169 - $917,610	11,473 Added 92.23%	23,913 $1.79 Million
Q1 2022 May 06, 2022	SELL	$61.48 - $73.72 $535,982 - $642,690	-8,718 Reduced 41.2%	12,440 $902,000
Q4 2021 Jan 28, 2022	SELL	$53.63 - $62.52 $293,195 - $341,796	-5,467 Reduced 20.53%	21,158 $1.32 Million
Q3 2021 Nov 08, 2021	BUY	$59.17 - $69.31 $1.11 Million - $1.31 Million	18,838 Added 241.92%	26,625 $1.58 Million
Q1 2021 May 14, 2021	BUY	$59.34 - $66.74 $63,553 - $71,478	1,071 Added 15.95%	7,787 $495,000
Q4 2020 Jan 14, 2021	BUY	$57.74 - $65.43 $387,781 - $439,427	6,716 New	6,716 $419,000
Q1 2020 May 12, 2020	SELL	$46.4 - $67.43 $74,100 - $107,685	-1,597 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $78,588 - $102,511	1,597 New	1,597 $102,000

2,425

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Americana Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Americana Partners, LLC with notifications on news.